The head of Hong Kong’s new drug regulatory body has pledged to build a fully capable and globally trusted agency that will become a catalyst for medical innovation rather than merely acting as a “miniature version” of existing overseas models. Dr Li Zili...
Building a globally trusted regulator rather than a copy of overseas models sounds like a meaningful step for Hong Kong's medical innovation. Curious how it will compare with mainland China, Singapore and Japan.…View moreView less
Building a globally trusted regulator rather than a copy of overseas models sounds like a meaningful step for Hong Kong's medical innovation. Curious how it will compare with mainland China, Singapore and Japan. #AsiaNews
wrote a new blog entry:
